After losing Adam Opiela to metastatic colon cancer at age 30, his family has partnered with a Dana-Farber research lab to ...

Metastatic colorectal cancer (mCRC) continues to increase among patients 45 and younger. Their longer survival and different ...

A new study from MIT and collaborators, published in Science, reveals a surprising culprit: ceramides, fatty molecules produced in response to a high-fat diet. The team discovered ...

Most colon cancer deaths are caused by the spread of tumor cells beyond the colon, usually to the liver. In a new study, MIT biologists identified a cellular pathway necessary for colorectal cancer ...

Older patients with metastatic colorectal cancer who undergo curative local treatment for metastases largely maintain quality of life and physical functioning over 1 year, a study shows.

Metastatic colorectal cancer remains one of the most stubborn frontiers in modern oncology, and a new review published in ...

Exelixis (NasdaqGS: EXEL) said the FDA has extended its review of zanzalintinib plus atezolizumab for metastatic colorectal cancer. The agency lengthened the decision timeline after Exelixis submitted ...

Colorectal cancer (CRC) remains a major global health burden, with emerging evidence implicating gut and oral microbiome dysbiosis in its pathogenesis. This comparative observational study aimed to ...

Greater walking was associated with reduced severe fatigue at 6 and 12 months and improved quality of life at each follow-up, ...

Tumor cell-intrinsic programs of metabolic adaptation and immune evasion in colorectal cancer liver metastases (CRCLMs). OS and PFS in pts who received fruquintinib with TS/ETS vs the ITT fruquintinib ...

Metastasis—the spread of cancer from a primary tumor to other parts of the body—causes most cancer-related deaths. But how ...